Genmab's experimental antibody-drug conjugate Rina-S reduced the risk of death by 57% compared to chemotherapy in patients with advanced ovarian cancer, according to phase 3 trial results presented at ESMO. The Danish drugmaker's shares surged over 12% on the news.
Snowflake's stock jumped 22% in after-hours trading following second quarter fiscal 2027 results that beat expectations on revenue, profit, and guidance. However, one metric—bookings—fell short of analyst expectations, raising questions about future growth momentum.
Unitree Robotics, the world's largest humanoid robot maker by sales, saw its shares jump more than 600% during its trading debut on Shanghai's STAR Market on Wednesday. The spectacular performance underscores China's rapid advancement in robotics technology.
Unitree Robotics, the world's largest humanoid robot maker by sales, saw its shares jump more than 600% during its trading debut on Shanghai's STAR Market on Wednesday. The spectacular performance underscores China's rapid advancement in robotics technology.
Unitree Robotics, the world's largest humanoid robot maker by sales, saw its shares jump more than 600% during its trading debut on Shanghai's STAR Market on Wednesday. The spectacular performance underscores China's rapid advancement in robotics technology.
Uber Technologies shares dropped sharply after the company issued third-quarter earnings guidance below analyst expectations while announcing plans to invest over $10 billion in robotaxi expansion. The weak outlook comes amid uncertainty over its partnership with Waymo, though Uber maintains the Alphabet unit remains an important partner.
Novo Nordisk reported quarterly results that beat expectations and raised guidance, but shares fell as investors remained concerned about the company's path to sustainable growth amid increasing competition in the obesity drug market.